Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy. - Wikidata - wikimedia - TriplyDB

Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.

Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.

http://www.wikidata.org/entity/Q38428834

about

The Nucleotide Oligomerization Domain-Like Receptors in Kidney Injury Inflammasomes in the Pathophysiology of Kidney Diseases Dealing with Danger in the CNS: The Response of the Immune System to Injury.High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy.Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.COX-2/mPGES-1/PGE2 cascade activation mediates uric acid-induced mesangial cell proliferation.Innate immunity in diabetes and diabetic nephropathy.Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis.NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.The NLRP3 inflammasome in kidney disease and autoimmunity.Inflammasomes in the urinary tract: a disease-based review.Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.Inflammasome Activation in Chronic Glomerular Diseases.Physiological functions and pathogenic potential of uric acid: A review.Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.Febuxostat Attenuates Renal Damage besides Exerting Hypouricemic Effect in Streptozotocin-Induced Diabetic Rats.High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway.Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway.Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome.Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury

P2860

Q26740429-A431C96A-FC44-488C-A0C9-A79CD577CA65 Q26740458-0ABA4E32-5539-45E9-81E4-B85A3490FA1F Q30279070-872A220D-A95F-4B8E-BA5F-B8AD43569907 Q33616618-AB33AA86-39FB-4171-B280-B13D18E620ED Q36153911-F5D414CF-D79C-43EE-B6B7-E8FC6AB43ABA Q37106734-CBB3B6B2-5E02-4365-A662-9C3C01B20FCE Q37705805-A9DF2CCA-E00F-4C1A-BF71-8DF91D7FA9D5 Q38633495-43741386-9207-4D05-B7FE-0FC5753B0B01 Q38708244-23FA7C84-41EE-4A53-8EB8-8F369B3A10A9 Q38717704-D3DADA62-DE38-49B5-9C08-69425C2ABCFD Q38721496-D0C6F16A-504F-4C16-9B77-255C0445D3A0 Q38787339-A67473AB-7AD8-4B2E-A262-B2BB0F176799 Q38832656-0646D083-F1B2-46D3-A58D-19DB0BBB74DA Q38925521-4AE3703B-BBF4-4D95-ABFA-AA029680857F Q38931056-EFDF33A5-44B4-4008-80E8-B69B4474620E Q40117885-E3184C66-A238-424A-8B64-206B67A8506A Q41017644-F4B044E6-B32F-4B89-A49C-16780636C1D4 Q41871493-407993D0-308B-40F8-B4EE-04A90D602B07 Q47826501-F8428FFC-0A2E-49E7-AA69-3E196D17CDFD Q49258083-16D0A341-CCAD-49F6-9778-324857443693 Q50946034-974D0C32-37CA-4272-8B10-6560983C8E35 Q54260312-59567A0C-2E41-482F-A2A3-488CF5E8E8AA Q55411801-51DFA746-5DA2-4609-883E-0564A297073E Q58548990-1D4E9832-B3CD-4707-81D9-669DD2F3DD65 Q59133411-E959A7B0-DA5A-4DB3-99F1-CC201AF5362F

P2860

Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.

http://www.wikidata.org/entity/Q38428834

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hyperuricemia-induced NLRP3 ac ...... ssion of diabetic nephropathy.

@en

type

label

Hyperuricemia-induced NLRP3 ac ...... ssion of diabetic nephropathy.

@en

prefLabel

Hyperuricemia-induced NLRP3 ac ...... ssion of diabetic nephropathy.

@en

P1433

Q38428834-1AC80EB3-75C2-400B-BBCF-2CC68926E272

P1476

Q38428834-B86C44B0-AAC6-4FB6-85EC-2C9CC9869259

P2093

Q38428834-70273213-0DB9-4066-B08F-1F73A6BF62AD

Q38428834-74D7840A-812B-4C3D-B8F9-7912481F89EF

Q38428834-752B68D3-B159-4197-A3C6-83DFCBD78BCC

Q38428834-899EE7B3-D428-493E-A16F-8F9C0957C321

Q38428834-AEAD3056-1AEE-4992-917C-18CD9C0E2741

Q38428834-B456B97F-ED48-44A6-86F1-501CAC03C876

Q38428834-BFDA9A58-8AA5-4E80-BA76-1868C510812C

Q38428834-D4A09631-2B6E-4544-A399-18A0B8F84C93

Q38428834-D790718B-81E0-45BC-83A5-DA40072BDC67

Q38428834-F3D52806-DC72-4514-8515-A53C293136C3

P2860

Q38428834-06EEECE8-F846-4E11-8F16-287EC871AF10

Q38428834-08CB425A-31B2-4771-9E69-F3D2D774A880

Q38428834-11E50AE8-9D81-495F-846D-22CEB616767D

Q38428834-172EC026-9570-4A43-AB62-07913BAFC375

Q38428834-1CB1C18D-69C7-40E0-BA17-5895BC1E490F

Q38428834-219ADACC-E70A-4BAD-8C7F-D82F9470343A

Q38428834-26E13394-F5DB-4660-BD7C-EA12D9FBBAB7

Q38428834-27290FE7-DDED-44BA-A505-429B6DF8D34A

Q38428834-284130F8-B816-464A-9A79-AB7BA6B3BCE6

Q38428834-3AFE7607-63D1-4B57-8DDA-C6133F70017D

P304

Q38428834-B4BE66B7-640B-49FA-8A0E-5B12DE8DA981

P31

Q38428834-B5962028-C1C1-416A-934D-539F5BF246EB

P356

Q38428834-8C0E8BA4-4C1E-4691-A7A5-DE820832D15A

P433

Q38428834-83D358BE-A367-47E4-BDD6-564481EBD100

P478

Q38428834-D7E6CB9F-2A4F-4FF2-99D9-4296766C6D76

P577

Q38428834-375B84E0-8F63-4883-8E41-BC1F45AD0B60

P5875

Q38428834-720F53BD-042B-46DD-B891-763796BCA6CF

P698

Q38428834-1B42FCB9-DD97-4544-BB00-A3EEA7226125

P356

AJPRENAL.00637.2014

P1433

American Journal of Physiology - Renal Physiology

P1476

Hyperuricemia-induced NLRP3 ac ...... ssion of diabetic nephropathy.

@en

P2093

Chun-Gyoo Ihm

http://www.w3.org/2001/XMLSchema#string

Dong-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Ju-Young Moon

http://www.w3.org/2001/XMLSchema#string

Jung-Woo Seo

http://www.w3.org/2001/XMLSchema#string

Kyu-Yeoun Won

http://www.w3.org/2001/XMLSchema#string

Kyung-Hwan Jeong

http://www.w3.org/2001/XMLSchema#string

Sang-Ho Lee

http://www.w3.org/2001/XMLSchema#string

Se-Yun Kim

http://www.w3.org/2001/XMLSchema#string

Su-Mi Kim

http://www.w3.org/2001/XMLSchema#string

Tae-Won Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice

Inflammation and metabolic disorders

Gout-associated uric acid crystals activate the NALP3 inflammasome

Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

Sterile inflammation: sensing and reacting to damage

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

NLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function.

The NLRP3 inflammasome promotes renal inflammation and contributes to CKD.

An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury

P304

F993-F1003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00637.2014

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

308

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272074535

http://www.w3.org/2001/XMLSchema#string

P698

25651569

http://www.w3.org/2001/XMLSchema#string